Clinical trials recruiting for Bipolar I Disorder
17
Recruiting trials
30
US states with sites
15
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| AL001 | 1 |
| Azetukalner | 1 |
| Cariprazine | 1 |
| Cariprazine Depot | 1 |
| Cariprazine Depot MTD | 1 |
| Icalcaprant | 1 |
| LB-102 | 1 |
| Lithium Carbonate | 1 |
| Magnesium vitamin B6 | 1 |
| NBI-1117568 | 1 |
| NMDAE | 1 |
| OLZ/SAM | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arkansas | 7 |
| California | 7 |
| Georgia | 7 |
| New York | 7 |
| Florida | 6 |
| Texas | 6 |
| Washington | 6 |
| Illinois | 5 |
| Ohio | 5 |
| Missouri | 4 |
| New Jersey | 4 |
| Colorado | 3 |
Top cities
Atlanta, Georgia 6Decatur, Georgia 5Everett, Washington 5Little Rock, Arkansas 5Chicago, Illinois 4Cincinnati, Ohio 4Garden Grove, California 4New York, New York 4Orange, California 4Austin, Texas 3
Self-screener
Recruiting trials
- A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolar I Disorder
- An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
- Children's Bipolar Network Treatment Trial I
- Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
- Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
- Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
- LHC-CIDI-5 in Hong Kong
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
- NMDA Receptor Modulation for the Treatment of Bipolar I Disorder
- Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
- SYNCED - SYNChronized Eating in Bipolar Depression Study
- Safety and Feasibility of DBS for Bipolar Depression
- Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Related conditions
Trials recruiting for Bipolar I Disorder often also study these conditions. Each links to its own recruiting-trial list.
Bipolar disorder 212Depression 1463Bipolar II Disorder 9Schizophrenia 386Bipolar Depression 22Anxiety 1237Suicidal Ideation 29Substance Use Disorder (SUD) 10Schizoaffective Disorder 31Schizo Affective Disorder 18
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Bipolar I Disorder trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.